Form 4: Alzamend Neuro Director Milton C. Ault III Reports Stock Purchase

Director Milton C. Ault III reports purchasing 5,000 shares of Alzamend Neuro, Inc. common stock at $0.962 per share.

Summary

• On March 18, 2025, Milton C. Ault III, a director and 10% owner of Alzamend Neuro, Inc. (ALZN), reported a transaction involving the company's common stock.
• Ault purchased 5,000 shares at a price of $0.962 per share.
• Following the transaction, Ault directly owns 16,686 shares.
• Ault also indirectly owns 82,368 shares through Ault Lending, LLC, 99,619 shares through Ault Life Sciences, Inc., and 549 shares through Ault Life Sciences Fund, LLC.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The director's purchase suggests confidence, but it's a relatively small transaction.

Positives

• The director's purchase could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely watched by investors as they can provide insights into a company's prospects. Purchases by directors are often seen as a positive sign.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates